XK and influenza: The literature claims that a higher mutation rate near the NA active region has caused a gradual decline in anti-influenza drug effectiveness, necessitating the search for new promising sources of bioactive agents that could simultaneously interact with other controlling sites (i.e., the 430-cavity) to disrupt enzyme activity [61,62].